1. Drug Discovery in Liver Disease Using Kinome Profiling
   Bingting Yu et al, 2021, IJMS CrossRef
2. null
   Dan Li et al, 2022 CrossRef
3. The NOP14 nucleolar protein suppresses the function and stemness of melanoma stem-like cells through Wnt/beta-catenin signaling inactivation
   Jingrong Li et al, 2022, Bioengineered CrossRef
4. Antitumor activity of T cells secreting αCD133-αCD3 bispecific T-cell engager against cholangiocarcinoma
   Thanich Sangsuwannukul et al, 2022, PLoS ONE CrossRef
5. Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective
   Haixiang Pei et al, 2022, Medicinal Research Reviews CrossRef
6. Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing
   Jing Bian et al, 2022, Stem Cells International CrossRef
7. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
   Richard E. Kast et al, 2022, Cancers CrossRef
8. FBXO31 sensitizes CSC‐like cells to cisplatin by promoting ferroptosis and facilitating proteasomal degradation of GPX4 in CCA
   Zhiwen Zhu et al, 2022, Liver International CrossRef
9. Overexpression of KiSS1 Induces the Proliferation of Hepatocarcinoma and Increases Metastatic Potential by Increasing Migratory Ability and Angiogenic Capacity
   Cho-Won Kim et al, 2022, Mol.Cells CrossRef
10. Establishment and characterization of a novel cancer stem‐like cell of cholangiocarcinoma
    Orasa Panawan et al, 2023, Cancer Science CrossRef
11. RAB6A functions as a critical modulator of the stem‐like subsets in cholangiocarcinoma
    Liangfang Yang et al, 2023, Molecular Carcinogenesis CrossRef
12. HELLS modulates the stemness of intrahepatic cholangiocarcinoma through promoting senescence-associated secretory phenotype
    Xiaojing Du et al, 2023, Computational and Structural Biotechnology Journal CrossRef
13. Single-cell RNA sequencing reveals cancer stem-like cells and dynamics in tumor microenvironment during cholangiocarcinoma progression
    Jihye L. Golino et al, 2023, Front. Cell Dev. Biol. CrossRef
14. LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling
    Shaobo Yu et al, 2024, Cancer Gene Ther CrossRef
15. Regulation of Hippo–YAP signaling axis by Isoalantolactone suppresses tumor progression in cholangiocarcinoma
    Cho-Long Kim et al, 2024, Translational Oncology CrossRef